Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Trouble Brewing For Some Of Jeffrey Altman’s Top Smid-Cap Picks Like Iron Mountain Inc (IRM)

Page 1 of 2

A portfolio formed around a smid-cap strategy offers the best of two worlds: landing comfortably between the relatively unknown nature of small-cap companies, which results in greater alpha opportunities, and the opportunity to benefit from the less volatile nature of larger mid-caps, something which is absent from a small-cap only strategy. In this regard we decided to take a closer look at how Jeffrey Altman has geared his fund, Owl Creek Asset Management‘s portfolio towards smid-cap companies with market caps of between $5 billion and $10 billion.

Jeffrey Altman

Jeffrey Altman graduated from Tulane University in 1988. Prior to establishing Owl Creek in June 2001, he worked as a portfolio manager at Franklin Mutual Advisers, LLC, where he focused on distressed securities. With regards to the fund’s performance during the financial crises, Owl Creek returned 40% in 2007, but lost 9% in the following year. In 2013 the fund’s bet on the Japanese economy paid off as it returned about 48% that year. Currently, the fund has about $5.82 billion worth of assets under management and the market value of its public equity portfolio stood at $1.85 billion at the end of March. The fund’s top smid-cap picks included Iron Mountain Inc (NYSE:IRM), Hertz Global Holdings Inc (NYSE:HTZ), and Service Corporation International (NYSE:SCI), which were three of its top six stock picks overall.

At Insider Monkey, we track hedge funds’ moves in order to identify actionable patterns and profit from them. Our research has shown that hedge funds’ large-cap stock picks historically underperformed the S&P 500 Total Return Index by an average of seven basis points per month between 1999 and 2012. On the other hand, the 15 most popular small-cap stocks among hedge funds outperformed the S&P 500 Index by an average of 95 basis points per month (read the details here). Since the official launch of our small-cap strategy in August 2012, it has performed just as predicted, returning over 142% and beating the market by 83 percentage points. We believe the data is clear: investors will be better off by focusing on small-cap stocks utilizing hedge fund expertise (while avoiding their high fees at the same time) rather than large-cap stocks.

Altman trimmed the stake of his second-largest equity holding overall, in Iron Mountain Inc (NYSE:IRM), by 2% during the fourth quarter to 4.40 million shares valued at $160.53 million. The holding represents 2.09% of the $6.74 billion provider of information management services’ outstanding common stock and 8.67% of Owl Creek’s portfolio value. Although still up slightly, by 3.29% over the past year, Iron Mountain Inc (NYSE:IRM)’s stock has slumped by over 17% year-to-date. Recently, Iron Mountain Inc (NYSE:IRM) entered into a binding Scheme Implementation Deed to acquire its Australian rival Recall Holdings for $2.6 billion. However, analysts don’t see this move resolving the company’s cash shortfall issues. Jeffries downgraded Iron Mountain Inc (NYSE:IRM) to ‘Underperform’ from ‘Hold’ and revised its price target downwards to $29 from $33. According to our database, Jonathan Jacobson‘s Highfields Capital Management is the largest stockholder of Iron Mountain Inc (NYSE:IRM), holding some 6.17 million shares valued at $224.91 million.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!